Lexaria Bioscience Corp LEXX

Alternate Symbol(s): LEXXW

Healthcare

Lexaria Bioscience Corp. is a Canada-based biotechnology company. The Company is engaged in pursuing the enhancement of the bioavailability of a diverse and a range of active pharmaceutical ingredients (API) using DehydraTECH, its patented proprietary drug delivery technology. The Company’s patented drug delivery technology, DehydraTECH, is designed to improve the way active molecules enter the bloodstream upon oral ingestion. DehydraTECH has also demonstrated enhanced delivery of certain active molecules into brain tissue. The Company has also developed DehydraTECH formulations for other applications demonstrating bio-absorption when administered intraorally and topically. It operates through two segments: Intellectual Property and Products. It also operates a licensed in-house research laboratory and holds an intellectual property portfolio with 35 patents granted and many patents pending worldwide. Its subsidiaries include Lexaria CanPharm ULC, and Lexaria CanPharm Holdings Corp.

NDAQ:LEXX - Post by User

Lexaria Bioscience Corp > lexxw Why they hit the common stock

<< Previous

Bullboard Posts

Next >>

Comment by WakeUPPon Jan 14, 2021 4:05pm

131 Views

Post# 32299299

RE:lexxw Why they hit the common stock

lasvegasPUMPEr wtf are you even talking about?

they "hit" the stock becuas eof $50k worth of warrant traded?

Gve yer head a shake

stop LYING all the time

GO abck to buyng all the LXX "for your fund" (ROFLMAO)

<< Previous

Bullboard Posts

Next >>

The top 10 artificial intelligence penny stocks